世界の代謝型グルタミン酸受容体3市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Metabotropic Glutamate Receptor 3 Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5853 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、代謝型グルタミン酸受容体3の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（LY-3020371、VU-0092273、DT-010991、その他）、用途別市場規模（自閉症、慢性疼痛、神経膠腫、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・代謝型グルタミン酸受容体3の市場動向 ・企業の競争状況、市場シェア ・代謝型グルタミン酸受容体3の種類別市場規模と予測2016-2027（LY-3020371、VU-0092273、DT-010991、その他） ・代謝型グルタミン酸受容体3の用途別市場規模と予測2016-2027（自閉症、慢性疼痛、神経膠腫、その他） ・代謝型グルタミン酸受容体3の北米市場規模2016-2027（アメリカ、カナダ） ・代謝型グルタミン酸受容体3の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・代謝型グルタミン酸受容体3のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・代謝型グルタミン酸受容体3の中南米市場規模2016-2027（メキシコ、ブラジル） ・代謝型グルタミン酸受容体3の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Addex Therapeutics Ltd、Aevi Genomic Medicine Inc、Denovo Biopharma LLC、Domain Therapeutics SA、Eli Lilly and Company、Prexton Therapeutics SA） ・結論

Market Analysis and Insights: Global Metabotropic Glutamate Receptor 3 Market
The global Metabotropic Glutamate Receptor 3 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metabotropic Glutamate Receptor 3 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metabotropic Glutamate Receptor 3 market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metabotropic Glutamate Receptor 3 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metabotropic Glutamate Receptor 3 market.

Global Metabotropic Glutamate Receptor 3 Scope and Market Size
Metabotropic Glutamate Receptor 3 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metabotropic Glutamate Receptor 3 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
LY-3020371
VU-0092273
DT-010991
Others

Segment by Application
Autism
Chronic Pain
Glioma
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Addex Therapeutics Ltd
Aevi Genomic Medicine Inc
Denovo Biopharma LLC
Domain Therapeutics SA
Eli Lilly and Company
Prexton Therapeutics SA

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metabotropic Glutamate Receptor 3 Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 LY-3020371
1.2.3 VU-0092273
1.2.4 DT-010991
1.2.5 Others
1.3 Market by Application
1.3.1 Global Metabotropic Glutamate Receptor 3 Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Autism
1.3.3 Chronic Pain
1.3.4 Glioma
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Metabotropic Glutamate Receptor 3 Market Perspective (2016-2027)
2.2 Metabotropic Glutamate Receptor 3 Growth Trends by Regions
2.2.1 Metabotropic Glutamate Receptor 3 Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Metabotropic Glutamate Receptor 3 Historic Market Share by Regions (2016-2021)
2.2.3 Metabotropic Glutamate Receptor 3 Forecasted Market Size by Regions (2022-2027)
2.3 Metabotropic Glutamate Receptor 3 Industry Dynamic
2.3.1 Metabotropic Glutamate Receptor 3 Market Trends
2.3.2 Metabotropic Glutamate Receptor 3 Market Drivers
2.3.3 Metabotropic Glutamate Receptor 3 Market Challenges
2.3.4 Metabotropic Glutamate Receptor 3 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Metabotropic Glutamate Receptor 3 Players by Revenue
3.1.1 Global Top Metabotropic Glutamate Receptor 3 Players by Revenue (2016-2021)
3.1.2 Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Players (2016-2021)
3.2 Global Metabotropic Glutamate Receptor 3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Metabotropic Glutamate Receptor 3 Revenue
3.4 Global Metabotropic Glutamate Receptor 3 Market Concentration Ratio
3.4.1 Global Metabotropic Glutamate Receptor 3 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metabotropic Glutamate Receptor 3 Revenue in 2020
3.5 Metabotropic Glutamate Receptor 3 Key Players Head office and Area Served
3.6 Key Players Metabotropic Glutamate Receptor 3 Product Solution and Service
3.7 Date of Enter into Metabotropic Glutamate Receptor 3 Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Metabotropic Glutamate Receptor 3 Breakdown Data by Type
4.1 Global Metabotropic Glutamate Receptor 3 Historic Market Size by Type (2016-2021)
4.2 Global Metabotropic Glutamate Receptor 3 Forecasted Market Size by Type (2022-2027)

5 Metabotropic Glutamate Receptor 3 Breakdown Data by Application
5.1 Global Metabotropic Glutamate Receptor 3 Historic Market Size by Application (2016-2021)
5.2 Global Metabotropic Glutamate Receptor 3 Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Metabotropic Glutamate Receptor 3 Market Size (2016-2027)
6.2 North America Metabotropic Glutamate Receptor 3 Market Size by Type
6.2.1 North America Metabotropic Glutamate Receptor 3 Market Size by Type (2016-2021)
6.2.2 North America Metabotropic Glutamate Receptor 3 Market Size by Type (2022-2027)
6.2.3 North America Metabotropic Glutamate Receptor 3 Market Size by Type (2016-2027)
6.3 North America Metabotropic Glutamate Receptor 3 Market Size by Application
6.3.1 North America Metabotropic Glutamate Receptor 3 Market Size by Application (2016-2021)
6.3.2 North America Metabotropic Glutamate Receptor 3 Market Size by Application (2022-2027)
6.3.3 North America Metabotropic Glutamate Receptor 3 Market Size by Application (2016-2027)
6.4 North America Metabotropic Glutamate Receptor 3 Market Size by Country
6.4.1 North America Metabotropic Glutamate Receptor 3 Market Size by Country (2016-2021)
6.4.2 North America Metabotropic Glutamate Receptor 3 Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Metabotropic Glutamate Receptor 3 Market Size (2016-2027)
7.2 Europe Metabotropic Glutamate Receptor 3 Market Size by Type
7.2.1 Europe Metabotropic Glutamate Receptor 3 Market Size by Type (2016-2021)
7.2.2 Europe Metabotropic Glutamate Receptor 3 Market Size by Type (2022-2027)
7.2.3 Europe Metabotropic Glutamate Receptor 3 Market Size by Type (2016-2027)
7.3 Europe Metabotropic Glutamate Receptor 3 Market Size by Application
7.3.1 Europe Metabotropic Glutamate Receptor 3 Market Size by Application (2016-2021)
7.3.2 Europe Metabotropic Glutamate Receptor 3 Market Size by Application (2022-2027)
7.3.3 Europe Metabotropic Glutamate Receptor 3 Market Size by Application (2016-2027)
7.4 Europe Metabotropic Glutamate Receptor 3 Market Size by Country
7.4.1 Europe Metabotropic Glutamate Receptor 3 Market Size by Country (2016-2021)
7.4.2 Europe Metabotropic Glutamate Receptor 3 Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size (2016-2027)
8.2 Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Type
8.2.1 Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Type (2016-2027)
8.3 Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Application
8.3.1 Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Application (2016-2027)
8.4 Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Region
8.4.1 Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Metabotropic Glutamate Receptor 3 Market Size (2016-2027)
9.2 Latin America Metabotropic Glutamate Receptor 3 Market Size by Type
9.2.1 Latin America Metabotropic Glutamate Receptor 3 Market Size by Type (2016-2021)
9.2.2 Latin America Metabotropic Glutamate Receptor 3 Market Size by Type (2022-2027)
9.2.3 Latin America Metabotropic Glutamate Receptor 3 Market Size by Type (2016-2027)
9.3 Latin America Metabotropic Glutamate Receptor 3 Market Size by Application
9.3.1 Latin America Metabotropic Glutamate Receptor 3 Market Size by Application (2016-2021)
9.3.2 Latin America Metabotropic Glutamate Receptor 3 Market Size by Application (2022-2027)
9.3.3 Latin America Metabotropic Glutamate Receptor 3 Market Size by Application (2016-2027)
9.4 Latin America Metabotropic Glutamate Receptor 3 Market Size by Country
9.4.1 Latin America Metabotropic Glutamate Receptor 3 Market Size by Country (2016-2021)
9.4.2 Latin America Metabotropic Glutamate Receptor 3 Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size (2016-2027)
10.2 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Type
10.2.1 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Type (2016-2027)
10.3 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Application
10.3.1 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Application (2016-2027)
10.4 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Country
10.4.1 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Addex Therapeutics Ltd
11.1.1 Addex Therapeutics Ltd Company Details
11.1.2 Addex Therapeutics Ltd Business Overview
11.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Introduction
11.1.4 Addex Therapeutics Ltd Revenue in Metabotropic Glutamate Receptor 3 Business (2016-2021)
11.1.5 Addex Therapeutics Ltd Recent Development
11.2 Aevi Genomic Medicine Inc
11.2.1 Aevi Genomic Medicine Inc Company Details
11.2.2 Aevi Genomic Medicine Inc Business Overview
11.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 3 Introduction
11.2.4 Aevi Genomic Medicine Inc Revenue in Metabotropic Glutamate Receptor 3 Business (2016-2021)
11.2.5 Aevi Genomic Medicine Inc Recent Development
11.3 Denovo Biopharma LLC
11.3.1 Denovo Biopharma LLC Company Details
11.3.2 Denovo Biopharma LLC Business Overview
11.3.3 Denovo Biopharma LLC Metabotropic Glutamate Receptor 3 Introduction
11.3.4 Denovo Biopharma LLC Revenue in Metabotropic Glutamate Receptor 3 Business (2016-2021)
11.3.5 Denovo Biopharma LLC Recent Development
11.4 Domain Therapeutics SA
11.4.1 Domain Therapeutics SA Company Details
11.4.2 Domain Therapeutics SA Business Overview
11.4.3 Domain Therapeutics SA Metabotropic Glutamate Receptor 3 Introduction
11.4.4 Domain Therapeutics SA Revenue in Metabotropic Glutamate Receptor 3 Business (2016-2021)
11.4.5 Domain Therapeutics SA Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Details
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 3 Introduction
11.5.4 Eli Lilly and Company Revenue in Metabotropic Glutamate Receptor 3 Business (2016-2021)
11.5.5 Eli Lilly and Company Recent Development
11.6 Prexton Therapeutics SA
11.6.1 Prexton Therapeutics SA Company Details
11.6.2 Prexton Therapeutics SA Business Overview
11.6.3 Prexton Therapeutics SA Metabotropic Glutamate Receptor 3 Introduction
11.6.4 Prexton Therapeutics SA Revenue in Metabotropic Glutamate Receptor 3 Business (2016-2021)
11.6.5 Prexton Therapeutics SA Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Metabotropic Glutamate Receptor 3 Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of LY-3020371
Table 3. Key Players of VU-0092273
Table 4. Key Players of DT-010991
Table 5. Key Players of Others
Table 6. Global Metabotropic Glutamate Receptor 3 Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Metabotropic Glutamate Receptor 3 Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Metabotropic Glutamate Receptor 3 Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Metabotropic Glutamate Receptor 3 Market Share by Regions (2016-2021)
Table 10. Global Metabotropic Glutamate Receptor 3 Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Metabotropic Glutamate Receptor 3 Market Share by Regions (2022-2027)
Table 12. Metabotropic Glutamate Receptor 3 Market Trends
Table 13. Metabotropic Glutamate Receptor 3 Market Drivers
Table 14. Metabotropic Glutamate Receptor 3 Market Challenges
Table 15. Metabotropic Glutamate Receptor 3 Market Restraints
Table 16. Global Metabotropic Glutamate Receptor 3 Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Metabotropic Glutamate Receptor 3 Market Share by Players (2016-2021)
Table 18. Global Top Metabotropic Glutamate Receptor 3 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabotropic Glutamate Receptor 3 as of 2020)
Table 19. Ranking of Global Top Metabotropic Glutamate Receptor 3 Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Metabotropic Glutamate Receptor 3 Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Metabotropic Glutamate Receptor 3 Product Solution and Service
Table 23. Date of Enter into Metabotropic Glutamate Receptor 3 Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Metabotropic Glutamate Receptor 3 Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Type (2016-2021)
Table 27. Global Metabotropic Glutamate Receptor 3 Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Metabotropic Glutamate Receptor 3 Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Application (2016-2021)
Table 31. Global Metabotropic Glutamate Receptor 3 Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Metabotropic Glutamate Receptor 3 Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Metabotropic Glutamate Receptor 3 Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Metabotropic Glutamate Receptor 3 Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Metabotropic Glutamate Receptor 3 Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Metabotropic Glutamate Receptor 3 Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Metabotropic Glutamate Receptor 3 Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Metabotropic Glutamate Receptor 3 Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Metabotropic Glutamate Receptor 3 Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Metabotropic Glutamate Receptor 3 Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Metabotropic Glutamate Receptor 3 Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Metabotropic Glutamate Receptor 3 Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Metabotropic Glutamate Receptor 3 Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Metabotropic Glutamate Receptor 3 Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Metabotropic Glutamate Receptor 3 Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Metabotropic Glutamate Receptor 3 Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Metabotropic Glutamate Receptor 3 Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Metabotropic Glutamate Receptor 3 Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Metabotropic Glutamate Receptor 3 Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size by Country (2022-2027) & (US$ Million)
Table 63. Addex Therapeutics Ltd Company Details
Table 64. Addex Therapeutics Ltd Business Overview
Table 65. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 3 Product
Table 66. Addex Therapeutics Ltd Revenue in Metabotropic Glutamate Receptor 3 Business (2016-2021) & (US$ Million)
Table 67. Addex Therapeutics Ltd Recent Development
Table 68. Aevi Genomic Medicine Inc Company Details
Table 69. Aevi Genomic Medicine Inc Business Overview
Table 70. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 3 Product
Table 71. Aevi Genomic Medicine Inc Revenue in Metabotropic Glutamate Receptor 3 Business (2016-2021) & (US$ Million)
Table 72. Aevi Genomic Medicine Inc Recent Development
Table 73. Denovo Biopharma LLC Company Details
Table 74. Denovo Biopharma LLC Business Overview
Table 75. Denovo Biopharma LLC Metabotropic Glutamate Receptor 3 Product
Table 76. Denovo Biopharma LLC Revenue in Metabotropic Glutamate Receptor 3 Business (2016-2021) & (US$ Million)
Table 77. Denovo Biopharma LLC Recent Development
Table 78. Domain Therapeutics SA Company Details
Table 79. Domain Therapeutics SA Business Overview
Table 80. Domain Therapeutics SA Metabotropic Glutamate Receptor 3 Product
Table 81. Domain Therapeutics SA Revenue in Metabotropic Glutamate Receptor 3 Business (2016-2021) & (US$ Million)
Table 82. Domain Therapeutics SA Recent Development
Table 83. Eli Lilly and Company Company Details
Table 84. Eli Lilly and Company Business Overview
Table 85. Eli Lilly and Company Metabotropic Glutamate Receptor 3 Product
Table 86. Eli Lilly and Company Revenue in Metabotropic Glutamate Receptor 3 Business (2016-2021) & (US$ Million)
Table 87. Eli Lilly and Company Recent Development
Table 88. Prexton Therapeutics SA Company Details
Table 89. Prexton Therapeutics SA Business Overview
Table 90. Prexton Therapeutics SA Metabotropic Glutamate Receptor 3 Product
Table 91. Prexton Therapeutics SA Revenue in Metabotropic Glutamate Receptor 3 Business (2016-2021) & (US$ Million)
Table 92. Prexton Therapeutics SA Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metabotropic Glutamate Receptor 3 Market Share by Type: 2020 VS 2027
Figure 2. LY-3020371 Features
Figure 3. VU-0092273 Features
Figure 4. DT-010991 Features
Figure 5. Others Features
Figure 6. Global Metabotropic Glutamate Receptor 3 Market Share by Application: 2020 VS 2027
Figure 7. Autism Case Studies
Figure 8. Chronic Pain Case Studies
Figure 9. Glioma Case Studies
Figure 10. Others Case Studies
Figure 11. Metabotropic Glutamate Receptor 3 Report Years Considered
Figure 12. Global Metabotropic Glutamate Receptor 3 Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Metabotropic Glutamate Receptor 3 Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Metabotropic Glutamate Receptor 3 Market Share by Regions: 2020 VS 2027
Figure 15. Global Metabotropic Glutamate Receptor 3 Market Share by Regions (2022-2027)
Figure 16. Global Metabotropic Glutamate Receptor 3 Market Share by Players in 2020
Figure 17. Global Top Metabotropic Glutamate Receptor 3 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabotropic Glutamate Receptor 3 as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Metabotropic Glutamate Receptor 3 Revenue in 2020
Figure 19. Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Type (2016-2021)
Figure 20. Global Metabotropic Glutamate Receptor 3 Revenue Market Share by Type (2022-2027)
Figure 21. North America Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Metabotropic Glutamate Receptor 3 Market Share by Type (2016-2027)
Figure 23. North America Metabotropic Glutamate Receptor 3 Market Share by Application (2016-2027)
Figure 24. North America Metabotropic Glutamate Receptor 3 Market Share by Country (2016-2027)
Figure 25. United States Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Metabotropic Glutamate Receptor 3 Market Share by Type (2016-2027)
Figure 29. Europe Metabotropic Glutamate Receptor 3 Market Share by Application (2016-2027)
Figure 30. Europe Metabotropic Glutamate Receptor 3 Market Share by Country (2016-2027)
Figure 31. Germany Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Metabotropic Glutamate Receptor 3 Market Share by Region (2016-2027)
Figure 41. China Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Metabotropic Glutamate Receptor 3 Market Share by Type (2016-2027)
Figure 49. Latin America Metabotropic Glutamate Receptor 3 Market Share by Application (2016-2027)
Figure 50. Latin America Metabotropic Glutamate Receptor 3 Market Share by Country (2016-2027)
Figure 51. Mexico Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Metabotropic Glutamate Receptor 3 Market Share by Country (2016-2027)
Figure 57. Turkey Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Metabotropic Glutamate Receptor 3 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Addex Therapeutics Ltd Revenue Growth Rate in Metabotropic Glutamate Receptor 3 Business (2016-2021)
Figure 61. Aevi Genomic Medicine Inc Revenue Growth Rate in Metabotropic Glutamate Receptor 3 Business (2016-2021)
Figure 62. Denovo Biopharma LLC Revenue Growth Rate in Metabotropic Glutamate Receptor 3 Business (2016-2021)
Figure 63. Domain Therapeutics SA Revenue Growth Rate in Metabotropic Glutamate Receptor 3 Business (2016-2021)
Figure 64. Eli Lilly and Company Revenue Growth Rate in Metabotropic Glutamate Receptor 3 Business (2016-2021)
Figure 65. Prexton Therapeutics SA Revenue Growth Rate in Metabotropic Glutamate Receptor 3 Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---